TherapeuticsMD Inc. (TXMD)
1.06
0.06 (6.31%)
At close: Jan 15, 2025, 11:40 AM
Price Reaction to Earnings Reports
This table provides an overview of how a stock's price historically reacted around earnings reports. It displays key metrics like price changes over specific timeframes and Relative Strength Index (RSI).
| Report Date | -3 Days | -2 Days | -1 Day | Open | High | Low | Close | +1 Day | +2 Days | +3 Days | +1 Week | -1 Week | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nov 14, 2023
(Q3) AMC Q3 2023 | 2.00 | 2.02 | 2.01 | 2.01 | 2.37 | 2.01 | 2.36 | 2.35 | 2.27 | 2.92 | 2.78 | 2.20 | ||
IV: - RSI: 32 TXMD % | 0% | 1.00% | 1.00% | 0.00%
| 17.91%
| 0.00%
| 17.41%
| -0.42% | -3.40% | 28.63% | 0.00% | -6.78% | ||
Aug 14, 2023
(Q2) BMC Q2 2023 | 4.00 | 3.96 | 3.85 | 3.84 | 3.85 | 3.70 | 3.84 | 3.66 | 3.65 | 3.75 | 3.84 | 4.12 | ||
IV: - RSI: 38 TXMD % | -0.25% | -1.00% | -1.00% | -0.26%
| 0.00%
| -3.90%
| -0.26%
| -4.69% | -0.27% | 2.74% | 0.52% | -1.44% | ||
May 15, 2023
(Q1) AMC Q1 2023 | 4.00 | 4.39 | 4.39 | 4.64 | 4.70 | 4.31 | 4.40 | 4.19 | 4.24 | 4.32 | 4.49 | 3.84 | ||
IV: - RSI: 67 TXMD % | 3.36% | 9.75% | 9.75% | 5.69%
| 7.06%
| -1.82%
| 0.23%
| -4.77% | 1.19% | 1.89% | 4.18% | -1.03% | ||
| Daily change and RSI 14 are based on the report date for BMO releases and the following day for AMC releases. | ||||||||||||||
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options Data
- Instant access to live options data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.